Murdoch-based Orthocell has received regulatory approval to commence sales of Remplir in Singapore, as the listed biotech company posts a second consecutive quarter of record revenue.
Aged care leader Aegis Care Group will further diversify into the health sector, with its second integrated facility after a consolidation of the business's ownership.
Perth-based Cosmetique Clinic owner Stormeur has gone to the market to raise up to $7 million to fund the expansion of its non-surgical services network.
John Poynton has been appointed to the Prostate Cancer Foundation of Australia's Prostate Cancer Future Fund committee, and revealed his own battle with the disease.
Burswood-based Resonance Health has announced it will open a second TrialsWest facility in WA to provide better access to clinic trials, after acquiring the company in April.
Megan Wynne-chaired APM Human Services has disclosed a major write-down in the value of goodwill from its prior acquisitions in a draft scheme submitted with financial regulators.
A promising treatment for cancer using a patient's own cells could begin clinic trials in Western Australia by the end of the year under a state government-backed initiative.
Perth-registered Singaporean regenerative medtech company Osteopore has struck an exclusive distribution agreement with global medtech leader Zimmer Biomet.
Western Australia will establish Australia's first dedicated RNA development centre for cancer treatments after $2 million was invested by the state government.
A tender to redevelop medical facilities in Paraburdoo and Tom Price is expected to be released next month, with the projects set to be delivered under a state government initiative.
Researchers from UWA and the Perron Institute have discovered a new set of cells which can protect blood vessel structure in the central nervous system, know as the blood-brain barrier.
Nedlands-based health tech innovator Proteomics International Laboratories has appointed Eurobio Scientific to distribute its PromarkerD test in France.
Leederville-based medical dermatology company Botanix has announced it will tap investors for $70 million to fund the launch of its recently US Food and Drug Administration approved Sofdra gel.
Leederville-based medical dermatology company Botanix has received US Food and Drug Administration approval for its Sofdra gel, used to treat excessive underarms sweating.
The Australian Competition and Consumer Protection has voiced concerns over Sigma's proposed acquisition of Chemist Warehouse, including potential barriers for other pharmacy retailers to expand.
